comparemela.com
Home
Live Updates
Nir Livneh - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Nir livneh - Page 1 : comparemela.com
Kamada : Other Information - Form 6-K -December 28, 2023 at 09:33 am EST
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer .
United states
Nir livneh
Karnit goldwasser
Lilach asher topilsky
Ishay davidi
Lilach payorski
Kost forer gabbay kasierer
David tsur
Commission file number
Exchange commission on
Company notice
Securities exchange
Kamada ltd
Company board of directors
Foreign private
Securities exchange act
Kamada : Results of Annual General Meeting of Shareholders held on December 28, 2023 -December 28, 2023 at 09:40 am EST
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of.
United states
Kost forer gabbay kasierer
Lilach asher topilsky
Nir livneh
Company board of directors
Securities exchange
Kamada ltd
Exchange commission on
Company notice
Commission file number
Foreign private issuer pursuant
Securities exchange act
File number
Annual general meeting
Weizmann science park
Proxy statement
Kamada : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: We cordially invite you to attend an.
United states
Tel aviv
State of israel
Aharon roni ofer
Karnit goldwasser
Jonathan hahn
Lilach asher topilsky
Nir livneh
Ishay davidi
David tsur
Benjamin dekel
Lilach payorski
Assaf itshayek
Qira ltd
Stock exchange outside israel
American stock transfer trust company
Kamada Ltd (NASDAQ:KMDA) Q1 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Kamada Ltd. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
United states
Nir livneh
David bautz
Chaime orlev
Beit kama
Brian ritchie
Hydrogen group
Israeli companies law
Kamada ltd
European medicines agency
Zacks small cap research
Exchange commission
Call transcript may
First quarter
Damir london
Chief executive
Kamada Reports Strong First Quarter 2023 Financial Results; Reiterates Revenue and Profitability Guidance
Total Revenues for First Quarter of 2023 were $30.7 Million, Up 9% Year-over-YearFirst Quarter 2023 EBITDA of $3.8 Million, Increase of 16% Year-over-YearSolid First Quarter Results and Expected. | May 24, 2023
City of
United kingdom
United states
Chaime orlev
Nir livneh
Beit kama
Brian ritchie
Kamada ltd
Israeli ministry of health
Company vice
Exchange commission
European medicines agency
Lifesci advisors
Company israeli facility
Us securities exchange
Globenewswire inc
vimarsana © 2020. All Rights Reserved.